EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS020-05059 
Organism
Homo sapiens 
Tissue/cell
CD34+ 
Coordinate
chr10:16994390-16996380 
Target genes
Number: 5             
NameEnsembl ID
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ZNF263MA0528.1chr10:16995914-16995935AGGGGAGGAAGGGAGGGAACA+6.12
ZNF263MA0528.1chr10:16995883-16995904AAAGGAAGGGGAGGAGAGGAA+6.35
ZNF263MA0528.1chr10:16995877-16995898TGAGGAAAAGGAAGGGGAGGA+6.37
ZNF263MA0528.1chr10:16995880-16995901GGAAAAGGAAGGGGAGGAGAG+6.37
ZNF263MA0528.1chr10:16995874-16995895AGATGAGGAAAAGGAAGGGGA+6.53
ZNF263MA0528.1chr10:16995892-16995913GGAGGAGAGGAAGGGGAAGAA+6.91
ZNF263MA0528.1chr10:16995897-16995918AGAGGAAGGGGAAGAAGAGGG+7.15
ZNF263MA0528.1chr10:16995889-16995910AGGGGAGGAGAGGAAGGGGAA+7
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_38654chr10:16992331-16997103HUVEC
SE_44397chr10:16992263-16995163NHDF-Ad
SE_44397chr10:16996064-16997065NHDF-Ad
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr101699582716995877
Number: 2             
IDChromosomeStartEnd
GH10I016950chr101699248616995282
GH10I016954chr101699606516997065
Enhancer Sequence
GGGGAACACA CAAACACACA TACATGTCAT ATGCTTTTCA TTTCTACTGA CCGTACAAAA 60
CAATTATTTG ATGAATAAAA CCATCAATGA TTTTTCTTCT TATTTCTAAA ATGCACGCCA 120
AGAAAGTTCT CCATAAGGAG AGCTGTACAT AAACCATGAG AAAACAGGAG CACAGTTTAT 180
ATTTTTAACA ATTATTCTTC AACTACAGGA AGTAGGAAGT GGCAAAAAGC AACAGATTAA 240
ATGTCTATGA ATTGCCTAAG TCATTCAAAC AAAATTCTTG CATGGATTCA CTTACACTGC 300
CCACTCATAA ATCATAGGCA TAGGGATAAT CTGCTTATAA ATGACCTCTT TTTTTCAGGA 360
AAATAAATAC TCAATTGAAT AAGGCTTCAT AAGGATGACT GTAGATTACT AGAGAAGAGC 420
AAAATTCGAT GTGAGTCTTG AAGAGGGAGA GGCGGTCACC GCTGGAGGGC GTAAGAGGAG 480
TCTTGCTGAG GAGGAGGCCG AGGCTAAACT AGGACTTGGA GGGTGAGAAA AGGGAGGCCA 540
GGGAGGGGAC TGCCTGAGCA GACACAGAGG AGCATCTATA GAGGCTCAGC TGGAGCATGG 600
GGTGCCCCAG GGATGTGGGT GACTGACGCT GGAGAGAGGT CAGGGTGGGT TCTGGGGCTC 660
TTGGTTAACA TCTGCAGGAG CTTGAGCTTT ATTCTCCAGG CCAGGTGGAG ACGGGACAGA 720
CATTGAGCAT TCCAATGGCA TGATCAGAGC AGGGCTTTTA CAGGCGACTT TGGAGAGAGA 780
TGGGGTAAGG GTAGGTGACT TTCAGGAGGT TGTTACAGTC CGGATGAAAG CTAGCAGGGA 840
CTTTTTACTA TGAAGCAACA AACAAGTGAA TAATAACATG CAAAAGAACT ATTAGGAAAC 900
TAGTTTTTCT TTAAAATCAA CAAGAATATA GTCTGTCTTG CTCCAAAGTC TAAAGGTCTA 960
TGGTGCGTAT TTGGGAGACC TCGATCCAGG CACTGTCCCC ATCCAGAGCT CTTTACTACA 1020
GAATATAAGC GAGTTGACTA AGATAGACAT AATGACTACA CAGACTAAAT GTATTTGTAG 1080
TGAATGTTCT GAGTCATCTG AATACAAGTC ATCTCTGACT ATGGGATAAG GGGTTCATCT 1140
CTTAGAACGA GCAGATGAAA GGCAATGGGT AAAAAGGTCT TGGAGAAGTG GTGATTTAAG 1200
AACAAAAATG GCCAGGTATG GTGGGAGGCT AAGACAGGAG AATCACTTGA GGCCAGGAGT 1260
TTGAGACCAG CCCGGGCAAC AGAGCAGATC CCATCTCTAA AAAAGAAAAA AAATAGCCAG 1320
GCGTGGGGGT GCACCTATAG TCCCAGCTAC TCAGGAGGCT GAGGTGGGAG GATTGCCTGA 1380
GCCTGGGAGG TCGAGGCTTC AGTGAGCCGT GATTGCACCA CTGCACTCCA GCCTGGGTGA 1440
CAGAGAGAGA CCCTGTGGAA AGAAAGGGAA GGGGAGGGAA AGAGAGATGA GGAAAAGGAA 1500
GGGGAGGAGA GGAAGGGGAA GAAGAGGGGA GGAAGGGAGG GAACAAAGAA AGAAAAATAA 1560
ATGGAAAACA ACAGTGACTC CTCAGTTGGA CAATGGCAGG ATTCAGAAAT GAGGGAAACC 1620
ACTGCTTCCA GGGGCTGGCA TCTGAATACA TTACAAGCAA GTCTTGTAAT TGATAGCAGT 1680
GTATCCCATT CTAGTGTAAA GCCTTGGGTA GTGCTAGATC AGTGAATTTG GATAAAACTT 1740
TTTTATACTG TTTCTAGTCT TAAAAGCACT TTTAAACTTG TTAGAGATGC GGGTCCAAAG 1800
GAAGTCAGAG AAGGAGAAGG TTACAAGCAT CAGGAGTTGG GATAATTGTA AGTCACAGTT 1860
CTTTTGTTCT ATTTAATTTT TTACATGTTA AGTAGAAGGC TGTGATCAAT TTCTGAGCAC 1920
AGGTCTCATT TCACTGTTGC ACCAAACAGA GCACTGAAGA TTTCTCTTGT GCCTGGGAAG 1980
ATCCACAGGG 1990